Australia-based jewelry brand Emma Pills has received influencer investment ahead of its U.S. launch.
“Emma would be so sweet and give to me some jewelry,” Oakley said. “I slowly watched the range develop. I didn’t at first have an intention to invest in or be a part of the brand.”-entrepreneur said.
Emma Pills is sold direct-to-consumer and at Australian retailer The Iconic. Oakley plans to work with U.S.-based retailers while strengthening the brand’s online business model.Oakley declined to offer a sales projection, but industry sources estimate Emma Pills will reach $1 million in revenue by 2023.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Zendaya, Emma Watson, Gemma Chan, and More of the Best Dressed Stars.Zendaya, Gemma_Chan, and more of the best-dressed stars of the week showed impeccable fashion.
Leer más »
Addison Rae Wore a Black Cutout Dress With a High Leg Slit for ELLE's 2021 Women in Hollywood EventAddison Rae Wore a Black Cutout Dress With a High Leg Slit For ELLE's 2021 Women In Hollywood Event
Leer más »
Whimsical Zodiac Jewelry for Each and Every Astrological SignDiscover Vogue’s edit of the chicest celestial and zodiac jewelry pieces from diamond-dusted pendants and delicate bracelets.
Leer más »
Report: Getting Out Of Bed In Morning Sharply Increases Risk Of Things Getting Even WorseWASHINGTON—According to a report published Thursday in the Journal Of Applied Psychology, the act of getting out of bed in the morning dramatically increases the risk of things becoming even worse. “No matter how bad things were upon waking up, the very moment our trial subjects pulled off the covers and stepped out…
Leer más »
Superyacht Influencer Interview: Chris Cecil-WrightChris Cecil-Wright has been helping clients build, buy, charter and sell superyachts for the last 25 years.
Leer más »
EU regulator starts real-time review of Merck's COVID-19 pillU.S. drugmaker Merck & Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults.
Leer más »